IPv6 Deployment
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $1,500,000 to $3,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- ODT Acquisition Liaison odtvendorexcellence@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring IT acquisition services to resume and complete Phase 1 of its IPv6 modernization program by enabling dual-stack capabilities across remaining network infrastructure, establishing the foundation for Phase 2 transition to IPv6-only operations in alignment with OMB M-21-07. The solicitation is estimated to release on 2026-08-01, with award targeted for 2027-02-01.
The estimated award value ranges from $1.5 million to $3 million. Inquiries may be directed to the FDA's Office of Division of Technology vendor excellence mailbox at odtvendorexcellence@fda.hhs.gov.
Forecast text
IT Acquisition: Resume and complete Phase 1 of FDA's IPv6 modernization by enabling dual-stack capabilities across remaining network infrastructure, establishing the foundation for Phase 2 transition to IPv6-only operations in alignment with OMB M-21-07
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast